Abstract
The presence of succinyl-coenzyme A: acetoacetate CoA--transferase (3-oxo acid-CoA transferase), an initiator of ketone body utilization in non-hepatic tissue was examined in a number of animal and human tumours of peripheral tissues. While enzyme levels in heart, kidney, lymphocytes and bladder were high, the tumours contained low or non-detectable levels of transferase activity, comparable with that of normal liver. The activities of acetoacetyl-CoA thiolase paralleled that of the transferase, except for the high activity in liver, and in all cases the tumour content of the enzyme was lower than that of the brain. The activity of 3-hydroxybutyrate dehydrogenase was similar in both normal and tumour tissue. The results indicate that tumours of non-hepatic tissues may be unable to metabolize ketone-bodies and suggest a therapeutic strategy for selective starvation of the tumour by dietary modification.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Tisdale, M., Brennan, R. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer 47, 293–297 (1983). https://doi.org/10.1038/bjc.1983.38
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.38
This article is cited by
-
Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study
Journal of Neuro-Oncology (2020)
-
A framework for examining how diet impacts tumour metabolism
Nature Reviews Cancer (2019)
-
Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients
Theoretical Biology and Medical Modelling (2018)
-
Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer
Oncogenesis (2016)
-
The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors
Current Treatment Options in Oncology (2015)